PINT PHARMA: Pint was established in 1993 as a spinout of the University of Austria. Initially focused on marketing prostaglandins, which it still sells under its own brand, Pint has since built a portfolio of in-licensed and internally developed drugs for oncology, rare disease, and specialty pharma indications.
Pint has direct commercial operations in Colombia, Mexico, Brazil, Venezuela, Peru, and the Dominican Republic.
Market Data 
Markets 
AI
